Axendia is a leading analyst and strategic advisory firm that focuses exclusively on the Life Sciences markets.
Since 2005, Industry stakeholders and regulators have relied on Axendia for trusted advice on Business, Regulatory and Technology issues and trends based on trusted sources.
We provide strategic advice that enables our clients to prepare for, adapt to and overcome disruption. To this end, we conduct primary quantitative and qualitative research that our clients leverage to support their strategies and enables them to make informed decisions based on their unique needs.
Axendia serves the entire Life Science ecosystem ranging from start-ups to Fortune 100 companies including: Life Science Organization, Technology & Service Providers, and Regulatory Agencies.
Axendia professionals offer a unique combination of deep hands-on industry experience coupled with forward thinking insights. We contribute to our client’s success by providing long-range visibility and helping them navigate the increasingly complex landscape.
To stay informed on the latest Industry trends, read Axendia’s Life Science Panorama, a Journal for Industry Executives, at: www.axendia.com/blog.
Our very own Consulting Industry Analyst Kelly Doering represented our team at the 2025 The Stellix Group Aspire event! Keep an eye out for Kelly’s event brief, where she’ll unpack the top takeaways and emerging themes! #StellixAspire2025
Yesterday’s The Stellix Group Aspire was an energetic gathering of life science professionals dedicated to collaboration and a commitment to the patient.
From CEO Jenn Azar ‘s opening remarks on connection and innovation to the interactive Stellix Customer Experience Center… to the panels on AI and Community and through to the keynote with author and futurist, Jamie Metzl , the vibe was optimistic!
So glad Axendia, Inc. could attend and cover this event - stay tuned for further insights!
Carrie F.Kelly DoeringDaniel MatlisMónica V. M.Sandra Rodriguez
Happy 45th Anniversary, Amgen!
We’re grateful for the privilege of collaborating with Amgen’s visionary teams on initiatives that bridge science, technology, and compliance. We’re proud to support your efforts to deliver high-quality, life-changing therapies—and to contribute to a culture that values innovation, operational excellence, and, above all, patients.
Here’s to 45 years of impact, and an exciting road ahead!
🎉 🥳 Happy 45 years! April 8, 1980, is Amgen's born day.
From humble beginnings as a pioneering biotech startup with just a handful of employees, we've come a long way. Now we have approximately 28,000 employees serving millions of patients, with 40 some medicines, and a presence in approximately 100 countries and regions.
We harness the best of biology and technology to take on the world’s toughest diseases across general medicine, rare disease, inflammation and oncology. But one thing has never changed: Our mission to serve patients.
These are only a few of our favorite milestones from the past 45 years—and we’re just getting started.
We are grateful for the opportunity to advise Honeywell | Life Sciences on the TrackWise Manufacturing Platform. “In the face of economic pressures, shifting market demands, and evolving regulatory requirements, the Life Sciences industry is at an inflection point,” said Daniel Matlis, President and Founder at Axendia. “Industry leaders must seize the opportunity to transform and leverage technological advancements to unify digital quality and manufacturing. Embracing modern technologies, Industry can significantly enhance operational effectiveness, improve product quality, streamline regulatory compliance, and accelerate time to market.”
This effort highlighted the need to break down silos for improve visibility, flexibility, and efficiency, enhancing resilience in response to market changes.
The Biopharma industry continues to invest in innovation aimed at improving patient outcomes. At Axendia, we remain committed to providing independent, research-based strategic advice that empowers organizations to thrive amidst disruption and complexity. Together, we can turn challenges into opportunities for success. 🚀
Grateful to Gary Iszatt, Martin Dowdall, Shawn Opatka, Steve McCarthy, Martin Magazzolo, Cynthia Babb, Bart Reitter, Fabrizio Maniglio, Chris PetersMónica V. M.Sandra RodriguezKelly DoeringEric M. Luyer
Today we announced Trackwise Manufacturing, one of the first AI-assisted platforms in the life sciences industry to integrate digital and physical manufacturing. Read the press release: https://lnkd.in/dNh3cW6X or visit us at Interphex booth 1369 today!
Are you going to be at the The Stellix Group Aspire event on April 10th in Foxborough, MA?
As you’re planning your day, be sure to keep an eye out for Kelly Doering, Consulting Industry Analyst with Axendia.
We’re excited to see old friends and meet some new. Please reach out ahead of time if you’d like to meet! Leave a note in the comments or DM Kelly directly.
https://lnkd.in/eMcYd947Daniel MatlisMónica V. M.Sandra Rodriguez
We are incredibly grateful for the opportunity to advise Siemens in shaping the Enterprise Recipe Management (ERM) solution from its inception. This effort provided valuable insights into the importance of bridging the gap between Research, Development, and Manufacturing—an essential step in breaking down data silos, fostering knowledge sharing across organizations, and driving improvements in resilience. Adopting these strategies enables organizations to build resilience and accelerate both time to market and time to volume, critical factors in today’s fast-paced Biopharma landscape.
Improved collaboration between Research, Development, and Manufacturing plays a key role in enabling Biopharma companies to standardize, scale, and improve operations while maintaining flexibility and ensuring regulatory compliance.
The Biopharma industry continues to lead in innovation, and it’s been an honor to contribute toward efforts that support its success.
At Axendia, we remain committed to providing independent, research-based strategic advice that empowers organizations to thrive amidst disruption and complexity. Together, we can turn challenges into opportunities for success. 🚀
We are especially grateful to Todd Lybrook, PMP, Jim Thompson, Andrew Whytock, Michel Claes, Ivo Backx, Arnaud Lassalle, Stefan Krauss, Julita Panek, Gerry Keane, Patrick Bossuyt, Vincent Boudou, Jennifer Petrosky, Kim M. EdwardsDaniel MatlisSandra RodriguezMónica V. M.Kelly DoeringEric Luyer
Enterprise Recipe Management rocks!
It's all about closing the gap between R&D and Manufacturing through breaking down data silos and fostering knowledge sharing across the organization - Novonesis has even claimed to cut this time in half!
Come and meet our experts in hall 9 at #HM25 👀
Vignir IsbergTodd Lybrook, PMP#Pharma#Siemens#Novonesis#DigitalEnterprise.
🚨 #AI is redefining Quality Management—are you leading the change or reacting to it? Flex's Garth Conrad and Axendia's Sandra Rodriguez collaborated on an article looking the seismic shift that is happening in the quality landscape.
What began with simple AI prompts has evolved into systems capable of independent decision-making. With each stage of maturity, we see fewer errors, less human intervention, and more strategic value.
Forward-thinking companies aren’t waiting for guidance—they’re helping shape it. By engaging with regulators and standards bodies, they're building the foundations for responsible AI governance in Life Sciences.
💡The truth? Strategic adoption beats reactive implementation every time.
There’s also a hidden cost in standing still. Outdated, manual, and error-prone processes are expensive to maintain and even more expensive to scale. Organizations that delay investment in AI-driven quality risk falling behind on compliance, cost control, and competitiveness.
Read the full article here and join in on the conversation: https://lnkd.in/dErAxdnR
